Ceragem Medisys

Ceragem Medisys was a South Korean medical device and in vitro diagnostics company focused on point-of-care testing products and selected consumer medical devices. The company developed and commercialized blood glucose monitoring systems, HbA1c analyzers, hemoglobin testing systems, and a light-therapy device for acne. It appears to have been founded in 2005 as a Ceragem affiliate and later acquired by the Green Cross group in 2015, after which it was renamed Green Cross Medis. The company was therefore health-care related and commercial-stage, but it does not appear to have operated as a therapeutics developer with a drug pipeline in the biotech/pharma sense.